BKV Corp. SEC Filings

BKV Corp: A shareholder filed a Form 144 notice to sell 6,518 common shares with an aggregate market value of $162,950. The filing lists Charles Schwab & Co., Inc. as broker, an approximate sale date of 11/06/2025, and trading on the NYSE.

Shares outstanding were 84,711,220. The notice also lists recent sales by the same seller, including 10,000 shares on 11/03/2025 for $233,700 and 22,669 shares on 11/05/2025 for $566,738.

BKV Corp reported an insider transaction on Form 4. The Chief Legal and Admin Officer sold common stock under a Rule 10b5-1 trading plan adopted on November 22, 2024. On November 5, 2025, 22,669 shares were sold at a weighted average price of $25.0006, with trades ranging from $25.00 to $25.035, leaving 143,672 shares directly owned afterward. On November 6, 2025, a further 6,518 shares were sold at $25.00, resulting in 137,154 shares directly owned following the transactions.

BKV Corp received a Form 144 notice from a shareholder to sell up to 22,669 common shares under Rule 144. The filing lists an approximate sale date of 11/05/2025, with an aggregate market value of $566,738. The designated broker is Charles Schwab & Co., Inc., and the shares are to be sold on the NYSE.

The shares were originally acquired on 05/01/2020 as Founders Shares. Recent activity by the same filer over the past three months includes sales of 10,000 shares on 08/12/2025 for $216,200 and 9,187 shares on 09/02/2025 for $212,984, among other transactions.

BKV Corp reported an insider transaction by its Chief Legal and Admin Officer. On 11/03/2025, the officer sold 10,000 shares of common stock at $23.37 per share, coded “S” for a sale. The trade was executed under a Rule 10b5-1 trading plan adopted on November 22, 2024.

After the sale, the officer directly holds 166,341 shares of BKV common stock.

BKV filed a Form 144 indicating a planned sale of 10,000 common shares, with an aggregate market value of $233,700. The approximate sale date is November 3, 2025, through Charles Schwab & Co., Inc. on the NYSE.

The shares were acquired as 5,111 founders shares on May 1, 2020 and 4,889 shares from a restricted stock lapse on January 1, 2025. Shares outstanding were 84,711,220 as of the filing’s reference line; this is a baseline figure, not the amount being sold.

In the past three months, the filer reported sales of 10,000 shares for $216,200 on August 12, 2025, 9,187 shares for $212,984 on September 2, 2025, and 15,000 shares for $347,816 on October 1, 2025.

BKV Corporation agreed to acquire one-half of Banpu Power US’s interest in their BKV‑BPP Power joint venture, which will leave the venture owned 75% by BKV and 25% by BPPUS. The purchase price is set by a formula of $376.0 million less 25% of the joint venture’s net indebtedness at closing, paid 50% in cash and 50% in BKV common stock. As of September 30, 2025, net indebtedness of the joint venture was approximately $581.8 million. The stock portion will be priced using a VWAP of $21.6609. BKV expects the transaction to close in the first quarter of 2026, after required conditions are met, including disinterested shareholder approval at BPP and mailing of a Schedule 14C information statement at least 20 business days before closing.

Post‑closing, BKV will consolidate the joint venture, which owns two combined‑cycle gas and steam turbine power plants in Temple, Texas (ERCOT North). Banpu North America Corporation, BKV’s majority stockholder, has delivered written consent approving the stock issuance. BPPUS has a 180‑day lock‑up on the stock consideration and will receive S‑3 demand and piggyback registration rights. BKV plans to fund the cash portion with cash on hand and borrowings under its reserve‑based lending facility, which was amended on October 27, 2025.

BKV Corporation filed a Form S-3 shelf registration to offer up to $1,000,000,000 of various securities and to register for resale up to 63,877,614 shares of common stock held by a selling stockholder. The prospectus describes potential offerings of common stock, preferred stock, rights, debt securities, guarantees, warrants and units, and states the company may issue securities from time to time in one or more series. The filing discloses the company completed its IPO on September 27, 2024, has 84,726,220 shares outstanding as of September 18, 2025, and that the last reported NYSE price was $23.74 per share on September 29, 2025. BKV describes four business lines — upstream gas production, midstream gathering/processing/transportation, power generation and CCUS — and sets net‑zero targets of scope 1 & 2 by early 2030s and scope 1, 2 & 3 by late 2030s. The prospectus notes that the selling stockholder’s resale proceeds will not go to BKV and highlights governance provisions (classified board, supermajority amendments, forum selection) and customary risk factor and forward‑looking statement disclosures.

BKV Corp insider notice reports a proposed sale under Rule 144 of 15,000 common shares through Charles Schwab with an aggregate market value of $347,816, and lists prior sales by the same person totaling 40,187 shares during the past three months for gross proceeds of $660,491 across three transactions. The shares to be sold were acquired on 08/22/2024 as equity compensation (RSU/PSU) from BKV Corp. The filing includes the seller's representation that they are not aware of undisclosed material adverse information. The notice identifies the broker as Charles Schwab & Co., Inc. and the planned approximate sale date as 10/01/2025.

BKV Corporation announced a series of credit and acquisition-related transactions tied to its pending Bedrock acquisition that materially affect its borrowing capacity, reserves and pro forma operating profile. The amendments increase lender commitments to $800.0 million and raise the borrowing base to $1.0 billion, add Bedrock Production, LLC and subsidiaries as guarantors and collateral grantors, and temporarily waive an automatic borrowing-base reduction tied to the incurrence of up to $600.0 million of specified additional debt. Pro forma for the transactions, BKVs proved reserves rise from 4.5 Tcfe to 5.2 Tcfe and pro forma Adjusted EBITDAX for the trailing twelve months would be $339.6 million. BKV reports a pro forma net leverage ratio of 1.4x and cash/availability under the credit facility of approximately $824 million as of June 30, 2025.